Balchem Corporation Stock

$161.19

0.49% today

Nasdaq, Aug 29, 09:08 pm CET

ISIN

US0576652004

Symbol

BCPC

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P SmallCap 600

Sector

Materials

Industry

Chemicals

Overview Dividends Analysts Charts News Strategies

Balchem Corporation Stock price

$161.99

+64.42 66.02% 5Y

Nasdaq, Closing price Thu, Aug 28 2025

-1.22 0.75%

ISIN

US0576652004

Symbol

BCPC

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P SmallCap 600

Sector

Materials

Industry

Chemicals

Key metrics

Basic

Market capitalization

$5.3b

Enterprise Value

$5.4b

Net debt

$126.4m

Cash

$65.4m

Shares outstanding

32.5m

Valuation (TTM | estimate)

P/E

37.2 | 31.1

P/S

5.3 | 5.0

EV/Sales

5.5 | 5.2

EV/FCF

35.2

P/B

4.2

Dividends

DPS

$0.87

Yield 1Y | 5Y

0.5% | 0.5%

Growth 1Y | 5Y

10.1% | 10.8%

Payout 1Y | 3Y

22.1% | 22.5%

Increased

15 Years

Financials (TTM | estimate)

Revenue

$985.9m | $1.0b

EBITDA

$242.1m | $277.3m

EBIT

$197.9m | $210.5m

Net Income

$142.8m | $168.9m

Free Cash Flow

$153.1m

Growth (TTM | estimate)

Revenue

5.8% | 9.6%

EBITDA

8.4% | 19.5%

EBIT

16.8% | 14.4%

Net Income

22.2% | 31.4%

Free Cash Flow

-3.5%

Financial Health

Equity Ratio

73.0%

Return on Equity

11.2%

ROCE

12.9%

ROIC

9.9%

Debt/Equity

0.2

EPS

$4.4

FCF per Share

$4.7

Short interest

2.2%

Employees

Rev per Employee

$690.0k

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Balchem Corporation Stock Analysis

Unlock Scores for Free

??

8 Analysts have issued a Balchem Corporation forecast:

7x Buy

88%

More details on Analyst Estimates Including Price Targets

8 Analysts have issued a Balchem Corporation forecast:

Buy

88%

Hold

13%

Analyst Estimates with Stock Price Targets

Financial data from Balchem Corporation

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	986 986	6% 6% 100%
- Direct Costs	633 633	3% 3% 64%
Gross Profit	353 353	12% 12% 36%
- Selling and Administrative Expenses	136 136	2% 2% 14%
- Research and Development Expense	18 18	13% 13% 2%
EBITDA	242 242	8% 8% 25%
- Depreciation and Amortization	44 44	18% 18% 4%
EBIT (Operating Income) EBIT	198 198	17% 17% 20%
Net Profit	143 143	22% 22% 14%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Balchem Corporation Stock News

Neutral

GlobeNewsWire

●

3 days ago

Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

MONTVALE, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the H.C.

Positive

The Motley Fool

●

28 days ago

Balchem (BCPC) Q2 EPS Jumps 16.5%

Balchem (BCPC 0.24%), a leading provider of nutritional ingredients and specialty chemicals, released its second quarter results on July 31, 2025. The key news: Balchem reported record GAAP revenue and non-GAAP profits, well surpassing analyst expectations for Q2 FY2025.

Neutral

Seeking Alpha

●

28 days ago

Balchem Corporation (BCPC) Q2 2025 Earnings Call Transcript

Balchem Corporation (NASDAQ:BCPC ) Q2 2025 Earnings Conference Call July 31, 2025 11:00 AM ET Company Participants Carl Martin Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Lee Harris - CEO, President & Chairman Conference Call Participants Anthony Polak - Unidentified Company Aegis Capital Corp. - Unidentified Company Daniel Scott Harriman - Sidoti & Com...

More Balchem Corporation News

Company Profile

marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in New Hampton, NY.

Head office	United States
CEO	Theodore Harris
Employees	1,379
Founded	1967
Website	balchem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now